Effect of time since exposure to Chlamydia trachomatis on Chlamydia antibody detection in women: A cross-sectional study

Sexually Transmitted Infections

Volumn 89, Issue 5, 2013, Pages 398-403

  Horner, Patrick J ^a,b   Wills, Gillian S ^c   Reynolds, Rosy ^d   Johnson, Anne M ^e   Muir, David A ^f   Winston, Alan ^c   Broadbent, Andrew J ^c   Parker, David ^g   McClure, Myra O ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NORTH BRISTOL NHS TRUST   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^g Novel Consulting Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL SYSTEM; GENITAL TRACT INFECTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; CHLAMYDIA SEROLOGY; IMMUNOLOGY; ISOLATION AND PURIFICATION; PREDICTIVE VALUE; SEROPREVALENCE; SEXUAL BEHAVIOR; TIME; UNITED KINGDOM;

ANTIBODIES; CHLAMYDIA SEROLOGY; CHLAMYDIA TRACHOMATIS; SEROPREVALENCE;

ADULT; ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREAT BRITAIN; HUMANS; PREDICTIVE VALUE OF TESTS; SEXUAL BEHAVIOR; TIME FACTORS;

EID: 84884187001     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050386     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. http://www.cdc.gov/std/treatment/2010/STD- Treatment-2010-RR5912.pdf
2. National Chlamydia Screening Programme. Health Protection Agency. 2011. http://www.chlamydiascreening.nhs.uk/ps/index.asp
3. Ward H, Fredlund H, Gotz H, et al. ECDC Guidance: Chlamydia control in Europe. 2009. http://www.ecdc.europa.eu/en/publications/Publications/0906-GUI- Chlamydia-Control-in-Europe.pdf
4. Low N. Screening programmes for chlamydial infection: when will we ever learn? BMJ 2007;334:725-8. (Pubitemid 46623736)
5. Genital Chlamydia trachomatis tests and diagnoses in young adults in England, 2011. Health Protection Report. 1 June 2012:6 (22).
6. House of Commons Committee of Public Accounts. Young people's sexual health: the National Chlamydia Screening Programme. 2010. http://www. publications. parliament.uk/pa/cm200910/cmselect/cmpubacc/283/283.pdf
7. Miller WC. Epidemiology of chlamydial infection: are we losing ground? Sex Transm Infect 2008;84:82-6. (Pubitemid 351497913)
8. Low N. Caution: chlamydia surveillance data ahead. Sex Transm Infect 2008;84:80-1. (Pubitemid 351497912)
9. Price M J P, Ades AP, Welton N J P, et al. How much tubal factor infertility is caused by chlamydia? Estimates based on serological evidence corrected for sensitivity and specificity. Sex Transm Dis 2012;39:608-13.
10. Johnson AM, Horner P. A new role for Chlamydia trachomatis serology? Sex Transm Infect 2008;84:79-80. (Pubitemid 351497911)
11. Wills GS, Horner PJ, Reynolds R, et al. Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of chlamydia trachomatis infection. Clin Vaccine Immunol 2009;16:835-43.
12. Persson K. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections. Best Pract Res Clin Obstet Gynaecol 2002;16:801-14. (Pubitemid 41123377)
13. Peeling RW, Wang SP, Grayston JT, et al. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis 2000;181(Suppl 3):S426-9. (Pubitemid 30416110)
14. Duncan B, Hart G, Scoular A, et al. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ 2001;322:195-9. (Pubitemid 32116161)
15. Lorimer K, Reid ME, Hart GJ. 'It has to speak to people's everyday life...": qualitative study of men and women's willingness to participate in a non-medical approach to Chlamydia trachomatis screening. Sex Transm Infect 2009;85:201-5.
16. Hosenfeld C B M, Workowski K A M, Berman SM, et al. Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009;36:478-89.
17. Clad A, Freidank HM, Kunze M, et al. Detection of seroconversion and persistence of Chlamydia trachomatis antibodies in five different serological tests. Eur Jo Clin Microbiol Infect Dis 2000;19:932-7. (Pubitemid 32206325)
18. Taylor-Robinson D, Stacey CM, Jensen JS, et al. Further observations, mainly serological, on a cohort of women with or without pelvic inflammatory disease. Int J STD AIDS 2009;20:712-18.
19. Svensson L, Westrom L, Ripa KT, et al. Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serologic findings. Am J Obstet Gynecol 1980;138:7-21.
20. Geisler WM, Suchland RJ, Whittington WL, et al. The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection. Sex Transm Dis 2003;30:160-5. (Pubitemid 36184366)
21. Eckert LO, Suchland RJ, Hawes SE, et al. Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. J Infect Dis 2000;182:540-4. (Pubitemid 30654823)
22. Weill FX, Le Hello S, Clerc M, et al. Serological reactivity and bacterial genotypes in Chlamydia trachomatis urogenital infections in Guadeloupe, French West Indies. Sex Transm Infect 2009;86:101-5.
23. Horner P, Wills G, Pebody R, et al. A comparative study of Chlamydia trachomatis PGP3 antibody elisa and two C trachomatis specific momp peptide assays on sera from young people in the community. Chlamydial infections: Proceedings of the Twelfth International Symposium on human Chlamydial Infections; 2010; San Francisco, CA 94110: International Chlamydia Symposium, 2010:453-6.
24. Oliver I, Camm J. Access to Genitourinary medicine clinics. South West STI Task Force Quarterly Bulletin 2005. http://www.hpa.org.uk/web/HPAwebFile/ HPAweb-C/1194947411400
25. Rekart ML, Brunham RC. Epidemiology of chlamydial infection: are we losing ground? Sex Transm Infect 2008;84:87-91. (Pubitemid 351497914)
26. Brunham RC, Pourbohloul B, Mak S, et al. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Inf Dis 2005;192:1836-44. (Pubitemid 41587838)